Interpretation of T cell states from single-cell transcriptomics data using reference atlases.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
20 05 2021
Historique:
received: 05 10 2020
accepted: 22 04 2021
entrez: 21 5 2021
pubmed: 22 5 2021
medline: 2 6 2021
Statut: epublish

Résumé

Single-cell RNA sequencing (scRNA-seq) has revealed an unprecedented degree of immune cell diversity. However, consistent definition of cell subtypes and cell states across studies and diseases remains a major challenge. Here we generate reference T cell atlases for cancer and viral infection by multi-study integration, and develop ProjecTILs, an algorithm for reference atlas projection. In contrast to other methods, ProjecTILs allows not only accurate embedding of new scRNA-seq data into a reference without altering its structure, but also characterizing previously unknown cell states that "deviate" from the reference. ProjecTILs accurately predicts the effects of cell perturbations and identifies gene programs that are altered in different conditions and tissues. A meta-analysis of tumor-infiltrating T cells from several cohorts reveals a strong conservation of T cell subtypes between human and mouse, providing a consistent basis to describe T cell heterogeneity across studies, diseases, and species.

Identifiants

pubmed: 34017005
doi: 10.1038/s41467-021-23324-4
pii: 10.1038/s41467-021-23324-4
pmc: PMC8137700
doi:

Banques de données

figshare
['10.6084/m9.figshare.12478571', '10.6084/m9.figshare.12489518']

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2965

Références

Cell. 2018 Nov 1;175(4):998-1013.e20
pubmed: 30388456
Nat Methods. 2019 Dec;16(12):1289-1296
pubmed: 31740819
Nature. 2017 Jul 27;547(7664):413-418
pubmed: 28723893
Nat Biotechnol. 2018 Jun;36(5):421-427
pubmed: 29608177
Nature. 2019 Dec;576(7787):465-470
pubmed: 31827286
Nat Rev Cancer. 2012 Mar 15;12(4):298-306
pubmed: 22419253
Genome Biol. 2020 Feb 7;21(1):31
pubmed: 32033589
Nature. 2018 May;557(7706):575-579
pubmed: 29769722
J Immunol. 2006 Sep 15;177(6):3903-12
pubmed: 16951353
Nature. 2019 Jul;571(7764):270-274
pubmed: 31207604
Nat Immunol. 2019 Feb;20(2):163-172
pubmed: 30643263
Elife. 2017 Dec 05;6:
pubmed: 29206104
Cancer Immunol Res. 2019 Jun;7(6):963-976
pubmed: 31064777
Nat Immunol. 2009 Jan;10(1):29-37
pubmed: 19043418
Nat Rev Immunol. 2020 Feb;20(2):128-136
pubmed: 31591533
Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12410-12415
pubmed: 31152140
Cell Rep. 2019 Dec 3;29(10):3019-3032.e6
pubmed: 31801070
Nat Med. 2019 Aug;25(8):1251-1259
pubmed: 31359002
Bioinformatics. 2021 May 5;37(6):882-884
pubmed: 32845323
Sci Transl Med. 2019 Oct 23;11(515):
pubmed: 31645454
Immunity. 2013 Apr 18;38(4):742-53
pubmed: 23601686
Nat Methods. 2020 Dec;17(12):1200-1206
pubmed: 33077966
Nat Immunol. 2019 Mar;20(3):326-336
pubmed: 30778252
JCI Insight. 2019 Mar 21;4(6):
pubmed: 30721153
Immunity. 2019 Dec 17;51(6):1043-1058.e4
pubmed: 31810882
J Immunol. 2005 Jun 1;174(11):6809-19
pubmed: 15905522
Immunity. 2019 Nov 19;51(5):840-855.e5
pubmed: 31606264
Cell. 2018 Aug 23;174(5):1293-1308.e36
pubmed: 29961579
Nat Commun. 2020 Jul 10;11(1):3458
pubmed: 32651388
Cell. 2018 Nov 1;175(4):984-997.e24
pubmed: 30388455
Nature. 2019 Jul;571(7764):265-269
pubmed: 31207605
Cell. 2019 Feb 7;176(4):775-789.e18
pubmed: 30595452
Nature. 2019 Dec;576(7787):471-476
pubmed: 31827283
Immunity. 2019 Jan 15;50(1):195-211.e10
pubmed: 30635237
Nat Methods. 2019 Aug;16(8):695-698
pubmed: 31308548
Immunity. 2019 Dec 17;51(6):1028-1042.e4
pubmed: 31810883
J Clin Invest. 2014 May;124(5):2246-59
pubmed: 24667641
Immunity. 2019 Nov 19;51(5):826-839.e5
pubmed: 31732165
Nature. 2014 Nov 27;515(7528):568-71
pubmed: 25428505
Nat Methods. 2018 May;15(5):359-362
pubmed: 29608555
Nat Biotechnol. 2019 Jun;37(6):685-691
pubmed: 31061482
F1000Res. 2020 Jan 27;9:47
pubmed: 32789006
Nat Med. 2019 Jan;25(1):89-94
pubmed: 30510250
Cell. 2019 Jun 13;177(7):1873-1887.e17
pubmed: 31178122
Neural Netw. 2000 May-Jun;13(4-5):411-30
pubmed: 10946390
Nat Methods. 2018 Dec;15(12):1053-1058
pubmed: 30504886
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Front Immunol. 2020 May 29;11:986
pubmed: 32547546
J Exp Med. 2010 Sep 27;207(10):2175-86
pubmed: 20819923
Nature. 2019 Jul;571(7764):211-218
pubmed: 31207603
Cell Rep. 2020 Aug 25;32(8):108078
pubmed: 32846135
Bioinformatics. 2020 Jun 1;36(11):3585-3587
pubmed: 32105316
Nucleic Acids Res. 2019 Jan 8;47(D1):D766-D773
pubmed: 30357393
Immunity. 2020 May 19;52(5):825-841.e8
pubmed: 32396847
Nat Immunol. 2019 Jul;20(7):890-901
pubmed: 31209400
Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):20070-20076
pubmed: 31530725
Front Immunol. 2020 Feb 27;11:340
pubmed: 32174925
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Cell. 2018 Dec 13;175(7):1744-1755.e15
pubmed: 30503208
Nat Immunol. 2013 Jun;14(6):593-602
pubmed: 23603793
Nat Rev Immunol. 2019 Nov;19(11):665-674
pubmed: 31570879
Oncoimmunology. 2020 Mar 12;9(1):1737369
pubmed: 32313720
Genome Biol. 2015 Dec 10;16:278
pubmed: 26653891
Nat Immunol. 2019 Oct;20(10):1335-1347
pubmed: 31527834
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7875-80
pubmed: 20385810
J Biomed Inform. 2010 Dec;43(6):932-44
pubmed: 20619355
Cell. 2016 Sep 8;166(6):1500-1511.e9
pubmed: 27610572

Auteurs

Massimo Andreatta (M)

Department of Oncology, Lausanne Branch, Ludwig Institute for Cancer Research, CHUV and University of Lausanne, Lausanne, Epalinges, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Jesus Corria-Osorio (J)

Department of Oncology, Lausanne Branch, Ludwig Institute for Cancer Research, CHUV and University of Lausanne, Lausanne, Epalinges, Switzerland.

Sören Müller (S)

Department of Bioinformatics and Computational Biology, Genentech, South San Francisco, CA, USA.

Rafael Cubas (R)

Department of Translational Oncology, Genentech, South San Francisco, CA, USA.

George Coukos (G)

Department of Oncology, Lausanne Branch, Ludwig Institute for Cancer Research, CHUV and University of Lausanne, Lausanne, Epalinges, Switzerland.

Santiago J Carmona (SJ)

Department of Oncology, Lausanne Branch, Ludwig Institute for Cancer Research, CHUV and University of Lausanne, Lausanne, Epalinges, Switzerland. santiago.carmona@unil.ch.
Swiss Institute of Bioinformatics, Lausanne, Switzerland. santiago.carmona@unil.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH